Compare PEN & GIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEN | GIL |
|---|---|---|
| Founded | 2004 | 1946 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 10.6B |
| IPO Year | 2015 | 1999 |
| Metric | PEN | GIL |
|---|---|---|
| Price | $319.18 | $59.21 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $360.14 | $78.00 |
| AVG Volume (30 Days) | 391.9K | ★ 779.4K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.65% |
| EPS Growth | ★ 1155.56 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $1,403,665,000.00 | N/A |
| Revenue This Year | $14.34 | $71.14 |
| Revenue Next Year | $13.71 | $5.20 |
| P/E Ratio | $388.48 | ★ $23.11 |
| Revenue Growth | ★ 17.50 | N/A |
| 52 Week Low | $221.26 | $46.00 |
| 52 Week High | $362.41 | $73.70 |
| Indicator | PEN | GIL |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 51.29 |
| Support Level | $302.19 | $59.09 |
| Resistance Level | $321.38 | $62.42 |
| Average True Range (ATR) | 2.72 | 1.61 |
| MACD | -0.44 | 0.36 |
| Stochastic Oscillator | 10.96 | 65.52 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. It is a leader in blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels, a business that has been greatly enhanced by the Hanesbrands acquisition. Gildan's brands include Hanes, Bali, Maidenform, Playtex, Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generated 90% of its sales in the US in 2025.